Search for Clinical Trial Results

Sponsored By

Cytomegalic Inclusion Disease - 21 Studies Found

Status Study
Completed Study Name: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
Condition: Cytomegalovirus Infection
Date: 2008-08-05
Interventions: Drug: Single arm (ganciclovir and valganciclovir) Patients received a short induction of IV ganciclovir
Terminated Study Name: Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant
Condition: Cytomegalovirus Infections
Date: 2005-10-17
Interventions:
  • Drug: Valganciclovir
  • Drug: Ganciclovir
Completed Study Name: Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy
Condition: Cytomegalovirus Infections
Date: 2015-10-23
Interventions: Other: Blood draw and MRI The study is observational. The treatment-plan of the underlying disease remai
Completed Study Name: Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
Condition: Cytomegalovirus Infections
Date: 2016-01-26
Interventions:
  • Drug: Drug conversion to sirolimus

Completed Study Name: Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
Condition:
  • Cytomegalovirus Infection
  • Preterm Infants

Date: 2010-07-26
Interventions: Procedure: ultrashort heat inactivation
Completed Study Name: CMV-CTL for the Treatment of CMV Infection After HSCT
Condition:
  • Cytomegalovirus Infections
  • Hematological Disease

Date: 2016-12-18
Interventions:
  • Biological: CMV-CTL donor deri
Completed Study Name: A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
Condition:
  • Cytomegalovirus Infections
  • HIV Infections

Date: 1999-11-02
Interventions: Drug: Ganciclovir
Completed Study Name: IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
Condition: Cytomegalovirus Infections
Date: 2006-02-21
Interventions:
  • Drug: Valganciclovir 900 mg or
Recruiting Study Name: Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Condition:
  • Transplantation Infection
  • Cytomegalovirus Infection

Date: 2014-09-01
Interventions:
  • Drug: Everolimus

Terminated Study Name: Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study
Condition: CMV Infection
Date: 2016-03-23
<<< Previous | Next >>>